Skip to content
BriaCellBriaCell
  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • BriaIMT
    • BriaOTS
    • MOA
    • PKCδ
    • Patents
    • Clinical Trials
    • Scientific Publications
  • Patients
    • What is BriaCell therapy?
    • How can cancer patients get BriaCell therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News and Events
    • Filings & Shareholder Info
    • Analyst Coverage
    • Email Alerts
    • Contact Us
Recent Events

ASCO 2018: Interview with Dr. Saveri Bhattacharya on the ongoing Ph I/IIa clinical trial with BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer

Posted on June 19, 2018March 14, 2019 by admin001

ASCO 2018: Interview with Dr. Saveri Bhattacharya on the ongoing Ph I/IIa clinical trial with BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancerarr

This entry was posted in Recent Events. Bookmark the permalink.
BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel
Initial Research Report (by RB Milestone Group) – BriaCell Therapeutics Corp. June 21, 2018
Recent News
  • BriaCell to Participate at Upcoming Conferences and Appoints Senior R&D Director May 11, 2021
  • BriaCell Announces Investor and Media Outreach Programs April 15, 2021
  • BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million April 12, 2021
  • BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021 April 12, 2021
  • BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021 March 30, 2021
Categories
  • Annual Reports
  • News and Events
    • Recent Events
    • Recent News
Archives
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • November 2014
  • April 2014

Corporate Office - Canada

Suite 300 - Bellevue Centre, 235 -15th Street,
West Vancouver, BC V7T 2X1

Tel: 604-921-1810
Fax: 604-921-1898

 

Corporate Office - USA

2929 Arch Street, 3rd Floor
Philadelphia, PA 19104

Tel: 1-888-485-6340
Fax: 424-245-3719

  • About Us
    • About BriaCell
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
    • Corporate Governance
    • Privacy Policy
  • Technology
    • BriaIMT
    • BriaOTS
    • MOA
    • PKCδ
    • Patents
    • Clinical Trials
    • Scientific Publications
  • Patients
    • What is BriaCell therapy?
    • How can cancer patients get BriaCell therapy?
    • Clinical Trial
    • Expanded Access
  • Recent Media
  • Investor Relations
    • Presentation & Fact Sheet
    • News and Events
    • Filings & Shareholder Info
    • Analyst Coverage
    • Email Alerts
    • Contact Us

Signup for our Email Alert!


    Copyright 2022 © Briacell.| All rights reserved | XML Sitemap | HTML Sitemap
    • About Us
      • About BriaCell
      • Board of Directors
      • Management Team
      • Scientific Advisory Board
      • Corporate Governance
      • Privacy Policy
    • Technology
      • BriaIMT
      • BriaOTS
      • MOA
      • PKCδ
      • Patents
      • Clinical Trials
      • Scientific Publications
    • Patients
      • What is BriaCell therapy?
      • How can cancer patients get BriaCell therapy?
      • Clinical Trial
      • Expanded Access
    • Recent Media
    • Investor Relations
      • Presentation & Fact Sheet
      • News and Events
      • Filings & Shareholder Info
      • Analyst Coverage
      • Email Alerts
      • Contact Us
    • Home
    • Sign Up for Email Alert
    • Careers
    • TSX-V:BCT: (%)
    • NASDAQ:BCTX: (%)